BMC CANCER

Literals

• dcterms:coverage
  • 2001-2020
• ou:categoriaSJR
  • Cancer Research (Q2)
  • Oncology (Q1)
  • Genetics (Q2)
• ou:codigoRevista
  • 1471-2407
• vcard:country-name
  • United Kingdom
• bibo:eissn
  • 1471-2407
• dcterms:identifier
  • 2011-2219
• bibo:issn
  • 1471-2407
• dcterms:publisher
  • BioMed Central Ltd.
• vcard:region
  • Western Europe
• ou:sjrMejorCuartil
  • Q1
• dcterms:title
  • BMC CANCER

Typed Literals

• ou:sjr
  • 1.541 (http://www.w3.org/2001/XMLSchema#Decimal)

Inverse Relations

• Has related: ou:publicadaEnRevista
  • Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing